Abstract
Heme catabolism by heme oxygenases (HOs) in macrophages and liver cells allows the heme–iron from red blood cell hemoglobin to be recycled, i.e., to undergo reuse. Mammalian HOs generate Fe(II) in the cytosol from where it is distributed for biochemical and regulatory needs (e.g., heme synthesis, DNA synthesis, and ferritin induction), or stored safely on ferritin, or exported via ferroportin 1 (FPN1) to transferrin for delivery to cells throughout the body. This whole body cycle of iron reclamation is also maintained by several sources of heme in addition to the phagocytosis of effete red blood cells by macrophages. Intravascular hemolysis, whether from the normal wear and tear of circulating erythrocytes or during disease and trauma, provides both hemoglobin–haptoglobin (Hb–Hp) and heme (derived from Hb) in the circulation and within cells. Hb–heme is rapidly oxidized and heme then dissociates.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hallberg L, Solvell L. Absorption of hemoglobin iron in man. Acta Med Scand. 1967;181:335–54.
Bjorn-Rasmussen E, Hallberg L, Isaksson B, et al. Food iron absorption in man. Applications of the two-pool extrinsic tag method to measure heme and nonheme iron absorption from the whole diet. J Clin Invest. 1974;53:247–55.
Smith A. Novel heme–protein interactions: some more radical than others. In: Warren MJ, Smith AG, editors. Tetrapyrroles: birth, life and death. Austin/New York: Landes Bioscience/Springer; 2009. p. 184–207.
Marro S, Barisani D, Chiabrando D, et al. Lack of haptoglobin affects iron transport across duodenum by modulating ferroportin expression. Gastroenterology. 2007;133:1261–71.
Watanabe J, Grijalva V, Hama S, et al. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1 containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem. 2009;3:18292–301.
Hebbel RP. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin Hematol. 1990;27:51–69.
Hebbel RP, Morgan WT, Eaton JW, et al. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA. 1988;85:237–41.
Tsemakhovich VA, Bamm VV, Shaklai M, et al. Vascular damage by unstable hemoglobins: the role of heme-depleted globin. Arch Biochem Biophys. 2005;436:307–15.
Rossi-Fanelli A, Antonini E, Caputo A. Pure native globin from human hemoglobin: preparation and some physico-chemical properties. Biochim Biophys Acta. 1958;28:221.
Watanabe S, Wakasugi K. Zebrafish neuroglobin is a cell-membrane-penetrating globin. Biochemistry. 2008;47:5266–70.
Li RC, Saleem S, Zhen G, et al. Heme–hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab. 2009;29:953–64.
Evans RW, Rafique R, Zarea A, et al. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem. 2008;13:57–74.
Lane DJ, Lawen A. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J Biol Chem. 2008;283:12701–8.
Lane DJ, Lawen A. A highly sensitive colorimetric microplate ferrocyanide assay applied to ascorbate-stimulated transplasma membrane ferricyanide reduction and mitochondrial succinate oxidation. Anal Biochem. 2008;373:287–95.
MacKenzie B, Takanaga H, Hubert N, Rolfs A, Hediger MA. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT-1). Biochem J. 2007;403:59–69.
Gao J, Zhao N, Knutson MD, et al. The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells. J Biol Chem. 2008;283:21462–8.
Schaer CA, Vallelian F, Imhof A, et al. Heme carrier protein (HCP-1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of inflammatory macrophage activation. J Leukoc Biol. 2008;83:325–33.
O’Callaghan KM, Ayllon V, O’Keeffe J, et al. Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking. J Biol Chem. 2010;285:381–91.
Allhorn M, Berggard T, Nordberg J, et al. Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood. 2002;99:1894–901.
Tenopoulou M, Kurz T, Doulias PT, et al. Does the calcein-AM method assay the total cellular ‘labile iron pool’ or only a fraction of it? Biochem J. 2007;403:261–6.
Cabantchik ZI, Glickstein H, Milgram P, et al. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem. 1996;233:221–7.
Imlay JA. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem. 2008;77:755–76.
Petryka ZJ, Pierach CA, Smith A, et al. Billiary excretion of exogenous hematin in rats. Life Sci. 1977;21:1015–20.
Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103–5.
Ginzburg YZ, Rybicki AC, Suzuka SM, et al. Exogenous iron increases hemoglobin in beta-thalassemic mice. Exp Hematol. 2009;37:172–83.
Galli A, Bergamaschi G, Recalde H, et al. Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br J Haematol. 2004;127:598–603.
Delaby C, Pilard N, Hetet G, et al. A physiological model to study iron recycling in macrophages. Exp Cell Res. 2005;310:43–53.
Chung J, Prohaska JR, Wessling-Resnick M. Ferroportin-1 is not upregulated in copper-deficient mice. J Nutr. 2004;134:517–21.
Delaby C, Pilard N, Puy H, et al. Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J. 2008;411:123–31.
Knutson MD, Vafa MR, Haile DJ, et al. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood. 2003;102:4191–7.
De Domenico I, Vaughn MB, Li L, et al. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006;25:5396–404.
Knutson MD, Oukka M, Koss LM, et al. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA. 2005;102:1324–8.
Alam J, Shibahara S, Smith A. Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem. 1989;264:6371–5.
Alam J, Cai J, Smith A. Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5′ sequences are required for induction by heme or heavy metals. J Biol Chem. 1994;269:1001–9.
Marziali G, Perrotti E, Ilari R, et al. Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol. 1997;17:1387–95.
Marro S, Chiabrando D, Messana E, et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position −7007 of the FPN1 promoter. Haematologica. 2010;95:1261–8.
Alam J, Stewart D, Touchard C, et al. Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem. 1999;274:26071–8.
Cianetti L, Segnalini P, Calzolari A, et al. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Haematologica. 2005;90:1595–606.
Zhang DL, Hughes RM, Ollivierre-Wilson H, et al. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab. 2009;9:461–73.
Madsen M, Moller HJ, Nielsen MJ, et al. Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region. J Biol Chem. 2004;279:51561–7.
Schaer DJ, Schaer CA, Buehler PW, et al. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood. 2006;107:373–80.
Schaer CA, Schoedon G, Imhof A, et al. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res. 2006;99:943–50.
Schaer DJ, Boretti FS, Schoedon G, et al. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol. 2002;119:239–43.
Buehler PW, Abraham B, Vallelian F, et al. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood. 2009;113:2578–86.
Marklund S. Determination of plasma or serum haemoglobin by peroxidase activity employing 2,2′-azino-di-(3-ethyl-benzthiazolinsulphonate-6) as chromogen. Scand J Clin Lab Invest. 1978;38:543–7.
Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221–6.
Nakai K, Ohta T, Sakuma I, et al. Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins. J Cardiovasc Pharmacol. 1996;28:115–23.
Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet. 1982;12(189–261):453–84.
McCormick DJ, Atassi MZ. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem. 1990;9:735–42.
Asleh R, Guetta J, Kalet-Litman S, et al. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res. 2005;96:435–41.
Asleh R, Marsh S, Shilkrut M, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res. 2003;92:1193–200.
Nakagawa K, Asami M. Lack of correlation between lysosomal enzyme activity and ascorbic acid content in brain of lead-treated animals. Toxicol Lett. 1986;30:219–22.
Fagoonee S, Gburek J, Hirsch E, et al. Plasma protein haptoglobin modulates renal iron loading. Am J Pathol. 2005;166:973–83.
Van Vlierberghe H, Langlois M, Delanghe J, et al. Haptoglobin phenotype 2–2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol. 2001;35:707–11.
Tolosano E, Fagoonee S, Garuti C, et al. Haptoglobin modifies the hemochromatosis phenotype in mice. Blood. 2005;105:3353–5.
Tolosano E, Hirsch E, Patrucco E, et al. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood. 1999;94:3906–14.
Sears DA, Huser HJ. Plasma hemoglobin binding and clearance in the rhesus monkey after hemolytic transfusion reactions. Proc Soc Exp Biol Med. 1966;121:116–21.
Langley GR, Owen JA, Padanyi R. The effect of blood transfusions on serum haptoglobin. Br J Haematol. 1962;8:392–400.
Gburek J, Verroust PJ, Willnow TE, et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol. 2002;13:423–30.
Sears D. Disposal of plasma heme in normal man and patients with intravascular hemolysis. J Clin Invest. 1970;49:5–14.
Sears DA. Plasma heme-binding in patients with hemolytic disorders. J Lab Clin Med. 1968;71:484–94.
Sears DA. Depletion of plasma hemopexin in man by hematin injections. Proc Soc Exp Biol Med. 1969;131:371–3.
Muller-Eberhard U, Bosman C, Liem HH. Tissue localization of the heme–hemopexin complex in the rabbit and the rat as studied by light microscopy with the use of radioisotopes. J Lab Clin Med. 1970;76:426–31.
Bissell DM, Hammaker L, Schmid R. Hemoglobin and erythrocyte catabolism in rat liver: the separate roles of parenchymal and sinusoidal cells. Blood. 1972;40:812–22.
Weibel ER, Staubli W, Gnagi HR, et al. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol. 1969;42:68–91.
Pimstone NR, Engel P, Tenhunen R, et al. Further studies of microsomal haem oxygenase: mechanism for stimulation of enzyme activity and cellular localization. S Afr Med J. 1971;205:169–74.
Kino K, Tsunoo H, Higa Y, et al. Hemoglobin–haptoglobin receptor in rat liver plasma membrane. J Biol Chem. 1980;255:9616–20.
Kino K, Tsunoo H, Higa Y, et al. Kinetic aspects of hemoglobin.haptoglobin–receptor interaction in rat liver plasma membranes, isolated liver cells, and liver cells in primary culture. J Biol Chem. 1982;257:4828–33.
Higa Y, Oshiro S, Kino K, et al. Catabolism of globin–haptoglobin in liver cells after intravenous administration of hemoglobin–haptoglobin to rats. J Biol Chem. 1981;256:12322–8.
Oshiro S, Nakajima H. Intrahepatocellular site of the catabolism of heme and globin moiety of hemoglobin-haptoglobin after intravenous administration to rats. J Biol Chem. 1988;263:16032–8.
Davies DM, Smith A, Muller-Eberhard U, et al. Hepatic subcellular metabolism of heme from heme–hemopexin: incorporation of iron into ferritin. Biochem Biophys Res Commun. 1979;91:1504–11.
Lim SK, Kim H, Ali A, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood. 1998;92:1870–7.
Arredouani M, Matthijs P, Van Hoeyveld E, et al. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology. 2003;108:144–51.
Smith A. Mechanisms of cytoprotection by hemopexin. In: Smith KM, Guilard R, Kadish KM, editors. Handbook of porphyrin science biochemistry of tetrapyrroles. Hackensack: World Scientific Publishing Co.; 2011. p. 217–356.
Muller-Eberhard U, Javid J, Liem HH, et al. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 1968;32:811–15.
Comporti M, Signorini C, Buonocore G, et al. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med. 2002;32:568–76.
Wagener FA, Volk HD, Willis D, et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 2003;55:551–71.
Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett. 2005;157:175–88.
Balla J, Vercellotti GM, Nath K, et al. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant. 2003;18 Suppl 5:v8–12.
Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol. 2007;18:414–20.
Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–60.
Chen L, Zhang X, Chen-Roetling J, et al. Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J Neurosurg. 2011;114:1159–67.
Mauk MR, Smith A, Grant Mauk A. An alternative view of the proposed alternative activities of hemopexin. Protein Sci. 2011;20:791–805.
Graca-Souza AV, Arruda MA, de Freitas MS, et al. Neutrophil activation by heme: implications for inflammatory processes. Blood. 2002;99:4160–5.
Arruda MA, Rossi AG, de Freitas MS, et al. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol. 2004;173:2023–30.
Wagener FA, Eggert A, Boerman OC, et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood. 2001;98:1802–11.
Liang X, Lin T, Sun G, et al. Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J Leukoc Biol. 2009;86:229–35.
Wagener FA, Feldman E, de Witte T, et al. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med. 1997;216:456–63.
Geurts N, Martens E, Van Aelst I, et al. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Biochemistry. 2008;47:2689–99.
Saso L, Leone MG, Mo MY, et al. Differential changes in alpha2-macroglobulin and hemopexin in brain and liver in response to acute inflammation. Biochemistry (Mosc). 1999;64:839–44.
Muller-Eberhard U, Bashore R. Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid. N Engl J Med. 1970;282:1163–7.
Ramachandran P, Boontheung P, Xie Y, et al. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res. 2006;5:1493–503.
Pong JC, Chu CY, Chu KO, et al. Identification of hemopexin in tear film. Anal Biochem. 2011;404:82–5.
Leak LV, Liotta LA, Krutzsch H, et al. Proteomic analysis of lymph. Proteomics. 2004;4:753–65.
Yang Z, Philips JD, Doty RT, et al. Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. J Biol Chem. 2010;285:28874–82.
Hunt RC, Hunt DM, Gaur N, et al. Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J Cell Physiol. 1996;168:71–80.
Morello N, Tonoli E, Logrand F, et al. Hemopexin affects iron distribution and ferritin expression in mouse brain. J Cell Mol Med. 2008;13:4192–204.
Kovtunovych G, Eckhaus MA, Ghosh MC, et al. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood. 2010;116:6054–62.
Drabkin DL. Heme binding and transport – a spectrophotometric study of plasma glycoglobulin hemochromogens. Proc Natl Acad Sci USA. 1971;68:609–13.
Tolosano E, Fagoonee S, Hirsch E, et al. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood. 2002;100:4201–8.
Hrkal Z, Vodrazka Z, Kalousek I. Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur J Biochem. 1974;43:73–8.
Bunn HF, Jandl JH. Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem. 1968;243:465–75.
Morgan WT, Liem HH, Sutor RP, et al. Transfer of heme from heme–albumin to hemopexin. Biochim Biophys Acta. 1976;444:435–45.
Beaven GH, Chen S-H, D’Albis A, et al. A spectroscopic study of the haemin–human–serum–albumin system. Eur J Biochem. 1974;41:539–46.
Diotallevi P, Balducci E, Canapa A, et al. Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD). Boll Soc Ital Biol Sper. 1988;64:531–8.
Luft S, Glińska-Urban D, Brzezińska B, et al. Serum hemopexin level in rheumatoid arthritis. Reumatologia. 1973;11:279–86.
Meiers HG, Lissner R, Mawlawi H, et al. Hemopexin levels of men and women in different age-groups (author’s transl). Klin Wochenschr. 1974;52:453–4.
Foidart M, Liem HH, Adornato BT, et al. Hemopexin metabolism in patients with altered serum levels. J Lab Clin Med. 1983;102:838–46.
Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta. 2001;312:13–23.
Liem HH, Tavassoli M, Muller-Eberhard U. Cellular and subcellular localization of heme and hemopexin in the rabbit. Acta Haematol. 1975;53:219–25.
Smith A, Morgan WT. Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem J. 1979;182:47–54.
Smith A, Hunt RC. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur J Cell Biol. 1990;53:234–45.
Smith A, Morgan WT. Transport of heme by hemopexin to the liver: evidence for receptor-mediated uptake. Biochem Biophys Res Commun. 1978;84:151–7.
Smith A, Morgan WT. Hemopexin-mediated transport of heme into isolated rat hepatocytes. J Biol Chem. 1981;256:10902–9.
Smith A, Farooqui SF, Morgan WT. The murine haemopexin receptor. Evidence that the haemopexin-binding site resides on a 20 kDa subunit and that receptor recycling is regulated by protein kinase C. Biochem J. 1991;276:417–25.
Okazaki H, Taketani S, Kohno H, et al. The hemopexin receptor on the cell surface of human polymorphonuclear leukocytes. Cell Struct Funct. 1989;14:129–40.
Taketani S, Kohno H, Tokunaga R. Cell surface receptor for hemopexin in human leukemia HL60 cells. Specific binding, affinity labeling, and fate of heme. J Biol Chem. 1987;262:4639–43.
Taketani S, Kohno H, Tokunaga R. Receptor-mediated heme uptake from hemopexin by human erythroleukemia K562 cells. Biochem Int. 1986;13:307–12.
Taketani S, Kohno H, Sawamura T, et al. Hemopexin-dependent down-regulation of expression of the human transferrin receptor. J Biol Chem. 1990;265:13981–5.
Van Dijk JP, Kroos MJ, Starreveld JS, et al. Expression of haemopexin receptors by cultured human cytotrophoblast. Biochem J. 1995;307:669–72.
Smith A, Ledford BE. Expression of the haemopexin-transport system in cultured mouse hepatoma cells. Links between haemopexin and iron metabolism. Biochem J. 1988;256:941–50.
Hvidberg V, Maniecki MB, Jacobsen C, et al. Identification of the receptor scavenging hemopexin–heme complexes. Blood. 2005;106:2572–9.
May P, Herz J, Bock HH. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol Life Sci. 2005;62:2325–38.
Heeren J, Grewal T, Jackle S, et al. Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J Biol Chem. 2001;276:42333–52338.
van Kerkhof P, Lee J, McCormick L, et al. Sorting nexin 17 facilitates LRP recycling in the early endosome. EMBO J. 2005;24:2851–61.
Alam J, Smith A. Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J Biol Chem. 1989;264:17637–40.
Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977;270:347–9.
Rish KR, Swartzlander R, Sadikot TN, et al. Interaction of heme and heme-hemopexin with an extracellular oxidant system used to measure cell growth-associated plasma membrane electron transport. Biochim Biophys Acta. 2007;1767:1107–17.
Heide K, Haupt H, Stoeriko K, et al. On the heme-binding capacity of hemopexin. Clin Chim Acta. 1964;10:460–9.
Sears DA, Huser HJ. Plasma hematin-binding and clearance in the rhesus monkey. Proc Soc Exp Biol Med. 1966;121:111–16.
Muller-Eberhard U. Hemopexin. N Engl J Med. 1970;283:1090–4.
Lane RS, Rangeley DM, Liem HH, et al. Plasma clearance of 125I-labelled haemopexin in normal and haem- loaded rabbits. Br J Haematol. 1973;25:533–40.
Conway TP, Morgan WT, Liem HH, et al. Catabolism of photo-oxidized and desialylated hemopexin in the rabbit. J Biol Chem. 1975;250:3067–73.
Wochner RD, Spilberg I, Iio A, et al. Hemopexin metabolism in sickle-cell disease, porphyrias and control subjects – effects of heme injection. N Engl J Med. 1974;290:822–6.
Muller-Eberhard U, Leim HH, Mathews-Roth M, et al. Plasma levels of hemopexin and albumin in disorders of porphyrin metabolism. Proc Soc Exp Biol Med. 1974;146:694–7.
Rosen H, Sears DA, Meisenzahl D. Spectral properties of hemopexin-heme. The Schumm test. J Lab Clin Med. 1969;74:941–5.
Neale FC, Aber GM, Northam BE. The demonstration of intravascular haemolysis by means of serum paper electrophoresis and a modification of Schumm’s reaction. J Clin Pathol. 1958;11:206–19.
Wheby MS, Barrett Jr O, Crosby WH. Serum protein binding of myoglobin, hemoglobin and hematin. Blood. 1960;16:1579–85.
Muller-Eberhard U, Cleve H. Immunoelectrophoretic studies of the beta1-haem-binding globulin (haemopexin) in hereditary haemolytic disorders. Nature. 1963;197:602–3.
Smith A. Intracellular distribution of haem after uptake by different receptors. Haem–haemopexin and haem-asialo-haemopexin. Biochem J. 1985;231:663–9.
Potter D, Chroneos ZC, Baynes JW, et al. In vivo fate of hemopexin and heme-hemopexin complexes in the rat. Arch Biochem Biophys. 1993;300:98–104.
Larsen R, Gozzelino R, Jeney V, et al. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010;2:51ra71.
Garby L, Noyes WD. J Clin Invest. 1959;38:1479–88.
Noyes WD, Bothwell TH, Finch CA. The role of the reticulo-endothelial cell in iron metabolism. Br J Haematol. 1960;6:43–55.
Bernhard HP, Darlington GJ, Ruddle FH. Expression of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev Biol. 1973;35:83–96.
Vinchi F, Gastaldi S, Silengo L, et al. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol. 2008;173:289–99.
Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198–201.
Delanghe JR, Philippe J, Moerman F, et al. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome. Clin Chim Acta. 2010;411:521–3.
Maniecki MB, Hasle H, Friis-Hansen L, et al. Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. Blood. 2008;112:1510–14.
Morse D, Choi AM. Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol. 2002;27:8–16.
Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557–68.
Donnelly LE, Barnes PJ. Expression of heme oxygenase in human airway epithelial cells. Am J Respir Cell Mol Biol. 2001;24:295–303.
Ewing JF, Maines MD. Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain. J Neurochem. 1993;60:1512–19.
Maines MD. Heme oxygenase 1 transgenic mice as a model to study neuroprotection. Methods Enzymol. 2002;353:374–88.
Maines MD, Mayer RD, Ewing JF, et al. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther. 1993;264:457–62.
Panahian N, Yoshiura M, Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem. 1999;72:1187–203.
Goda N, Suzuki K, Naito M, et al. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest. 1998;101:604–12.
Dore S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA. 1999;96:2445–50.
Sung L, Morales P, Shibata M, et al. Defenses against extracellular heme-mediated oxidative damage: use of iron and copper chelators to investigate the role of redox active iron, copper and heme in the hemopexin heme transport system. In: Badman DG, Bergeron RJ, Brittenham GM, editors. Iron chelators: new development strategies. Sarotoga: Saratoga Publishing Group; 2000. p. 67–86.
Hori R, Kashiba M, Toma T, et al. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. J Biol Chem. 2002;277:10712–18.
Lin Q, Weis S, Yang G, et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007;282:20621–33.
Suttner DM, Sridhar K, Lee CS, et al. Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells. Am J Physiol. 1999;276:L443–51.
Lin QS, Weis S, Yang G, et al. Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radic Biol Med. 2008;44:847–55.
Taille C, El-Benna J, Lanone S, et al. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem. 2005;280:25350–60.
Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002;348:93–112.
Yi L, Jenkins PM, Leichert LI, et al. Heme regulatory motifs in heme oxygenase-2 form a thiol/disulfide redox switch that responds to the cellular redox state. J Biol Chem. 2009;284:20556–61.
Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 1997;94:10919–24.
Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997;94:10925–30.
Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129–35.
Ferris CD, Jaffrey SR, Sawa A, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999;1:152–7.
Mostert V, Nakayama A, Austin LM, et al. Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice. Drug Metab Rev. 2007;39:619–26.
Eisenstein RS, Garcia-Mayol D, Pettingell W, et al. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA. 1991;88:688–92.
Sheftel AD, Kim SF, Ponka P. Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J Biol Chem. 2007;282:10480–6.
Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 1999;13:1800–9.
Dennery PA, Spitz DR, Yang G, et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest. 1998;101:1001–11.
Dennery PA, Visner G, Weng YH, et al. Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. Free Radic Biol Med. 2003;34:124–33.
Fogg S, Agarwal A, Nick HS, et al. Iron regulates hyperoxia-dependent human heme oxygenase 1 gene expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol. 1999;20:797–804.
Smith A. Role of redox-active metals in the regulation of the metallothionein and heme oxygenase gene by heme and hemopexin. In: Ferreira GC, Moura JJG, Franco R, editors. Iron metabolism: inorganic biochemistry and regulatory mechanisms. Weinheim: Wiley-VCH Verlag GmbH; 2008. doi:10.1002/9783527613700.ch05.
Casey JL, Hentze MW, Koeller DM, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240:924–8.
Ren Y, Smith A. Mechanism of metallothionein gene regulation by heme-hemopexin. Roles of protein kinase C, reactive oxygen species, and cis-acting elements. J Biol Chem. 1995;270:23988–95.
Eskew JD, Vanacore RM, Sung L, et al. Cellular protection mechanisms against extracellular heme: heme–hemopexin, but not free heme, activates the N-terminal c-Jun kinase. J Biol Chem. 1999;274:638–48.
Vanacore R, Eskew J, Morales P, et al. Role for copper in transient oxidation and nuclear translocation of MTF-1, but not of NFκB, by the hemopexin heme transport system. Antioxid Redox Signal. 2000;2:739–52.
Smith A, Eskew JD, Borza CM, et al. Role of heme-hemopexin in human T-lymphocyte proliferation. Exp Cell Res. 1997;232:246–54.
Timmins GS, Davies MJ, Song DX, et al. EPR studies on the effects of complexation of heme by hemopexin upon its reactions with organic peroxides. Free Radic Res. 1995;23:559–69.
Moss D, Fargion S, Fracanzani AL, et al. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem. 1992;47:219–27.
Thompson KJ, Fried MG, Ye Z, et al. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;115:2165–77.
Campanella A, Rovelli E, Santambrogio P, et al. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet. 2009;18:1–11.
Radisky DC, Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J. 1998;336:201–5.
Worwood M. Serum ferritin. Crit Rev Clin Lab Sci. 1979;10:171–204.
Ghosh S, Hevi S, Chuck SL. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood. 2004;103:2369–76.
Kannengiesser C, Jouanolle AM, Hetet G, et al. A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica. 2009;94:335–9.
Cozzi A, Corsi B, Levi S, et al. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275:25122–9.
Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30:84–9.
Takami M, Mizumoto K, Kasuya I, et al. Human placental ferritin receptor. Biochim Biophys Acta. 1986;884:31–8.
Blight GD, Morgan EH. Transferrin and ferritin endocytosis and recycling in guinea-pig reticulocytes. Biochim Biophys Acta. 1987;929:18–24.
Adams PC, Mack U, Powell LW, et al. Isolation of a porcine hepatic ferritin receptor. Comp Biochem Physiol B. 1988;90:837–41.
Osterloh K, Aisen P. Pathways in the binding and uptake of ferritin by hepatocytes. Biochim Biophys Acta. 1989;1011:40–5.
Anderson GJ, Faulk WP, Arosio P, et al. Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells. Br J Haematol. 1989;73:260–4.
Moss D, Powell LW, Arosio P, et al. Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells. J Lab Clin Med. 1992;119:273–9.
Gelvan D, Fibach E, Meyron-Holtz EG, et al. Ferritin uptake by human erythroid precursors is a regulated iron uptake pathway. Blood. 1996;88:3200–7.
Moss D, Powell LW, Arosio P, et al. Effect of cell proliferation on H-ferritin receptor expression in human T lymphoid (MOLT-4) cells. J Lab Clin Med. 1992;120:239–43.
Sibille JC, Kondo H, Aisen P. Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine. Biochim Biophys Acta. 1989;1010:204–9.
Liao QK, Kong PA, Gao J, et al. Expression of ferritin receptor in placental microvilli membrane in pregnant women with different iron status at mid-term gestation. Eur J Clin Nutr. 2001;55:651–6.
Hulet SW, Hess EJ, Debinski W, et al. Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem. 1999;72:868–74.
Todorich B, Zhang X, Slagle-Webb B, et al. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem. 2008;107:1495–505.
Li JY, Paragas N, Ned RM, et al. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell. 2009;16:35–46.
Fisher J, Devraj K, Ingram J, et al. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol. 2007;293:C641–9.
Kearney SL, Nemeth E, Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer. 2007;48:57–63.
Acknowledgments
The author is grateful to Mr. Taron Davies for his help with the figures, which were based with permission on earlier diagrams of Drs. GJ Anderson and DM Frazer, and to Mr. Peter Hahl for help with the bibliography. Thanks also to both Drs Anderson and McClaren for their editorial support. The author wishes to acknowledge the help of colleagues in both the heme and iron fields, collaborators, technicians, students, and post-doctoral fellows who have contributed to her research on the hemopexin system and to the funding agencies including NIH, AHA, and UMRB that have supported the research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Smith, A. (2012). Iron Salvage Pathways. In: Anderson, G., McLaren, G. (eds) Iron Physiology and Pathophysiology in Humans. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-485-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-485-2_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-484-5
Online ISBN: 978-1-60327-485-2
eBook Packages: MedicineMedicine (R0)